There are some evidence to suggest that Chinese herbal medicine is a likely treatment or remedy against COVID-19.
In the coronavirus prevention and control, traditional Chinese herbal medicine has played an active and important role. Since the outbreak of the New Crown epidemic started from Wuhan, China, several patented Chinese herbal medicine hav been recommended by Chinese central government and many provinces and cities for COVID-19 diagnosis and treatment programs.
One of the Chinese herbal medicine is Lianhua Qingwen Capsules which has become the most recommended Chinese patent medicine.
The top scientist of the country, Academician Zhong Nanshan and his team have confirmed that Lianhua Qingwen has a significant inhibitory effect on the cytopathic effects of COVID-19 treatment; it can infect cells and induce TNF-A, IL-6 and other inflammatory diseases Factor overexpression has an inhibitory effect. The medicine brings an alternative treatment for new coronavirus, especially for mild and moderate symptoms of COVID-19, and helps relieve the urgent need for epidemic resistance.
In the large-scale use of the medicine Lianhua Qingbing in the epidemic areas, has shown good results. On February 7, 2020, 11 patients with new crown pneumonia in Huanggang City, Hubei Province were cured and discharged.
Dr. Liu Yi, the team leader of a Medical Support team working in Huanggang, said: “Our treatment is mainly antiviral therapy, the proprietary Chinese medicine Lianhua Qingwen, and the western medicine Lopi Nawei, and symptomatic support at the same time.”
According to the research published in the” World TCM “,” Journal of Traditional Chinese Medicine “,” “Chinese Journal of Experimental Traditional Medical Formulae”, the herbal medicine significantly improves the conditions in treating and relieving fever, cough, and fatigue symptoms in common patients and suspected patients with COVID-19. It reduces fever, fatigue, and cough, and provides research evidence for clinical treatment of the disease.
Lianhua Qingwen is a new Chinese medicine developed during the SARS period in 2003. According to the study conducted by the Chinese Academy of Military Medical Sciences, the results showed that Lianhua Qingwen capsule inhibited SARS-CoV virus The effective half concentration (IC50) is 0.09mg / ml, and its therapeutic index is 40.33, which can significantly inhibit the replication of SARS virus.
On January 27, 2020, the National Health and Medical Commission and the State Administration of Traditional Chinese Medicine issued the “Diagnosis and Treatment of Pneumonia of New Coronavirus Infection (Trial Version 4)”. Capsules (granules) have become the recommended traditional Chinese herbal medicine for this diagnosis and treatment plan for fatigue and fever with clinical manifestations during the medical observation period.
In 2015, another new type of coronavirus caused the Middle East Respiratory Syndrome. The National Health and Medical Commission also recommended Lianhua Qingwen Capsule / Granule as a preventive medicine in the diagnosis and treatment plan.
Lianhua Qingwen is a very common traditional Chinese medicine used for many years for the treatment of cold and flu. Composed of 13 herbal components, it has shown curative effects on mild and moderate patients, especially in relieving fever, cough and fatigue.
Ingredients of Lianhua Qingwen:
lianqiao (连翘, or forsythia fruit), jinyinhua (金银花, or honeysuckle), zhimahuang (炙麻黄, or honey-fried herba ephedrae), yuxingcao (鱼腥草, or herba houttuyniae), dahuang (大黄, or rhubarb root and rhizome), hongjingtian (红景天, or rhodiola root), banlangen (板蓝根, or radix isatidis), and so on.
